Prescription by generic name under fire

Published: 2007-02-22 07:00:00

Updated: 2007-02-22 07:00:00

The 'Participatory Government' cannot avoid severe criticism on its performance on the prescription by generic name, as the government yet failed to resolve the controversial issue, according to theCitizens' Coalition for Economic Justice (CCEJ).

In a recent health-related forum organized by R...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK